<DOC>
	<DOCNO>NCT00006360</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . PURPOSE : Phase I/II trial study effectiveness radiation therapy treat patient stage II stage III oropharyngeal cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Stage II Stage III Oropharyngeal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Assess target coverage major salivary gland spar patient stage II III oropharyngeal cancer treat intensity-modulated radiotherapy . - Determine nature prevalence acute late side effect treatment patient . - Determine rate pattern locoregional tumor recurrence patient treatment . OUTLINE : This multicenter study . Patients receive 3-D conformal radiotherapy and/or intensity-modulated radiotherapy daily 5 day week 6 week , effort spare major salivary gland . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : Approximately 57-64 patient accrue study 27 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage II III ( T1T2 , N0N1 ) squamous cell carcinoma oropharynx ( tonsil , base tongue , palate ) Lymph nod side neck risk metastatic disease require radiotherapy Patients upstage image N2 eligible Measurable evaluable disease Greater 1 cm one dimension necrotic region CT MRI scan Surgery primary tumor lymph node limit incisional excisional biopsy No distant metastasis PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No active untreated infection No malignancy within past 5 year except nonmelanoma skin cancer carcinoma head neck origin No concurrent major medical psychiatric illness would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : More 3 month since prior chemotherapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior head neck radiotherapy Surgery : See Disease Characteristics Other : No concurrent treatment head neck cancer No prophylactic amifostine pilocarpine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>